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Abstract

Research Question

• Inclusion of screening electrocardiograms (EKGs) during
pre-participation physical examination has been a topic of
debate for some time. There is unquestioned usefulness
in the ability of a well-trained health care provider in using
EKG to identify cardiac abnormalities.
• Further, there have been several contemporary EKG
criteria published that increase specificity and sensitivity of
detection of disease. However, these criteria do not
account for athletes less than 14 years of age, and that
demographic represents a large portion of patients
seeking pre-participation screenings in the United States.
• The lack of research into pediatric cardiac remodeling
secondary to activity, coupled with the significant overlap
in normal pediatric EKG findings with adult pathological
EKG findings create a difficult position for any health care
provider.
• A literature review was performed to determine if
screening EKGs are effective both medically and
economically in athletes less than 14 years of age.
• Based on the review, the limitations of contemporary EKG
criteria, the inability to prove cost effectiveness in the US
healthcare model, and the lack of research into activity
modulated pediatric cardiac remodeling should reinforce
that the ACC/AHA checklist is an appropriate foundation
for conducting pre-participation physical examination.

In patients requiring pre-participation physical examination,
would EKG be an effective screening tool, both medically
and economically, to identify conditions that may cause SCD
in athletes younger than 14 years old?

Introduction
• Pre-participation physical examinations are routinely
conducted in the United States in an effort to protect
young athletes.
• There are numerous estimates regarding the incidence of
sudden cardiac death (SCD) in athletes, ranging from one
in 40,000 to one in 80,000, and though SCD is a rare
occurrence the multifactorial effects on the surrounding
community cannot be denied.
• The majority of recommendations surrounding these
physicals support gathering a personal and family history
of cardiovascular disease as well as a physical
examination.

Statement of the Problem
• Many of the underlying pathologies that lead to SCD
produce subtle findings on exam and are difficult for even
an experienced Primary Care Provider to detect
(Finocchiaro et al., 2016).
• Between 2013 and 2023, 170 million high school and
college athletes will require pre-participation physical
examination. No estimate is available for primary school
children.

Economic Impact

Literature Review
Contemporary EKG interpretation criteria
• The European Society of Cardiology (ESC) released
recommendations intended to improve specificity
secondary to increasing number of unacceptably high
levels of false positive EKGs.
• The ESC recommendations were followed by the Seattle
and refined criteria, which further improved sensitivity and
reduced the abnormal rate of EKG to 9.6% and 6.6%
(p<0.001) respectively.

EKG abnormality

ESC recommendations

Seattle Criteria

Refined criteria

• Corrado et al., (2006) reported a marked decline in SCD
among athletes after the implementation of Italian law
mandating EKG screening.
• Halkin et al. (2012) recognized that the Corrado study
failed to address economic impact. They executed a costprogression model that estimated the cost of screening
EKG would reach $69 billion in the US by 2023.
• European studies provide more favorable economic
outcomes, reducing cost to approximately $87 dollars per
athlete (Dhutia et al., 2016), but the data lacks portability
to the US secondary to dissimilar health care models and
degree of subsidization.
Current recommendations
• The American Heart Association and the American
College of Cardiology recommend a 14 item checklist
when executing a pre-participation screening:

14 Element Cardiovascular Screening Checklist for Congenital and Genetic Heart Diseases
Personal History

Left atrial enlargement

Negative portion of the P
wave in lead V1 > 0.1 mV
in depth and > 40 ms in
duration

Prolonged P wave
duration of > 120 ms in
lead I or II with negative
portion of the P wave > 1
mm in depth and > 40
ms in duration in lead V1

As ESC

As ESC

Right atrial
enlargement

P wave amplitude > 2.5
mm in lead II, III, or aVF

As ESC

Left QRS axis
deviation

-30 to -90 degrees

As ESC

As ESC

Right QRS axis
deviation

> 115 degrees

As ESC

AS ESC

Right ventricular
hypertrophy

Complete LBBB

Sum of R wave in V1 and
Sum of R wave in V1
S wave in V5 or V6 > 10.5 and S wave in V5 > 10.5
mm
and right axis deviation >
120 degrees
QRS > 120 ms,
predominantly negative
QRS complex in lead V1
(QS or rS), and upright
monophasic R wave in
leads I and V6

As ESC

RSR’ pattern in anterior
precordial leads with QRS
duration > 120 ms

Not relevant

Intraventricular
conduction delay

Any QRS duration > 120
ms including RBBB and
LBBB

Pathological Q wave

1.

Chest pain/discomfort/tightness/pressure related to exertion

2.

Unexplained syncope/near syncope*

3.

Excessive exertional and unexplained dyspnea/fatigue or palpitations associated with
exercise

4.

Prior recognition of a heart murmur

5.

Elevated systemic blood pressure

6.

Prior restriction from participation in sports

7.

Prior testing for the heart, ordered by a physician
Family History

8.

Premature death (sudden and unexplained, or otherwise) before age 50 attributable to heart
disease in > 1 relative

9.

Disability from heart disease in close relative < 50 years of age

10.

Hypertrophic of dilated cardiomyopathy, long QT syndrome, or other ion challenopatihes,
Marfan syndrome, or clinically significant arrhythmias, specific knowledge of certain cardiac
conditions in family members

As ESC

As ESC

Physical Examination
11.

Heart murmur**

12.

Femoral pulses to exclude aortic coarctation

13.

Physical stigmata of Marfan syndrome

As ESC

14.

Brachial artery pressure (sitting position, preferably taken in both arms

Any QRS duration > 140
ms or complete LBBB

As ESC

*Judged not to be of a neurocardiogenic (vasovagal) origin; of particular concern when occurring
during or after physical exertion.
**Refers to heart murmurs judged to be organic and unlikely to be innocent; auscultation should be
performed with the patient in both the supine and standing positions (or with Valsalva maneuver),
specifically to identify murmurs of dynamic left ventricular outflow tract obstruction.

> 4 mm deep in any lead
except III, aVR

>3 mm deep or > 40 ms
duration in > 2 leads
except III and aVR

> 40 ms duration or
>25% of the height of
the ensuing R wave

Significant T wave
inversion

> 2 mm in > 2 adjacent
leads (deep) or “minor” in
> 2 leads

> 1 mm in depth in > 2
leads V2-V6, II and aVF,
or I and aVL (excludes
III, aVR, and V1)

As Seattle criteria

ST segment
depression

> 0.5 mm deep in > 2
leads

As ESC

As ESC

Ventricular preexcitation

PR interval < 120 ms with
or without delta wave

PR interval < 120 ms
with delta wave

As Seattle criteria

Complete RBBB

From “Comparison of Electrocardiographic Criteria for the Detection of Cardiac Abnormalities in Elite Black and
White Athletes”, by N. Sheikh, M. Papadakis, S. Ghani, A. Zaidi S. Gati, P.E. Adami, F. Carre F. Schnell, M. Wilson,
P. Avila, W. McKenna, S. Sharma, 2014, Circulation, 129(16), p. 1640. Copyright 2014 American Heart Association
Inc. Reprinted with permission.

Discussion

ACC/AHA Release Recommendations for Congenital and Genetic Heart Disease Screenings in
Youth (2014). Retrieved from http://www.acc.org/latest-in-cardiology/articles/2014/09/15/14/24/accaha-release-recommendations-for-congenital-and-genetic-heart-disease-screenings-in-youth.

Discussion
• None of the contemporary criteria included children less
than 14 years of age in their studies, nor were they
intended for use by primary care clinicians alone.
• Leger et al. (2016) point out that there is a significant
overlap in normal pediatric EKG findings with adult
pathological EKG findings, and that no current data exists
on the physiologic cardiac modifications related to
exercise in children thus making EKG less effective as a
screening tool in children than adults.

Applicability to Clinical
Practice
• Concerns for the provider when interpreting an athlete’s
EKG include both missing a dangerous cardiac condition
and generating false-positive interpretations that cause
needless further investigations, increased economic cost,
and potentially unnecessary activity restriction for the
athlete (Drezner et al., 2013).
• The ACC/AHA check sheet provides an appropriate
foundation for screening. If suspect findings present
themselves, specialist referral prior to participation is
appropriate.
• Provider-directed risk stratification of proposed activity
levels is also appropriate.
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